£900K
The seed round was led by Qima and will fund product development and team expansion.
"We are thrilled to have secured this investment enabling us to accelerate a 10 year product vision into an immediate reality."
Funding Announcements
Filter
Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 21 October 2026.
Announcements
1,488
Total raised
£42.7B
disclosed amounts
This month
£62.8M
raised so far
£5.0M
Golden Record Ventures led the £5m growth round to help Orbital expand its licensing and product offerings.
"We believe all modern, global companies will require access to both blockchain and fiat payment rails, from one single platform, to effectively manage their business in the future. Orbital has been built by veterans who deeply understand the needs of large enterprises, which until now have been massively underserved. Our combined expertise in both traditional finance and crypto means that we are uniquely positioned to serve their demands. Bootstrapped and profitable since 2017, we’ve both grown rapidly and raised financing in a very difficult crypto bear market. Now we’re ready to scale even further and push our platform towards the bleeding edge of fintech."
£7.9M
The financing round was co-led by Ecosystem Integrity Fund and SJF Ventures to support international expansion and product development.
"Revalue exists to deliver a fundamental step-change in integrity at scale. This drives us every day,"
The pre-seed round was led by Haatch alongside angel investors to fund product enhancement and customer growth.
"The market for application modernisation is primed for a fresh approach, and we believe AppFactor is poised to deliver just that. We are excited to be on the growth journey with AppFactor who has the potential to be a game-changing platform."
$2.7M
The London based healthtech startup secured backing from investors including Entrepreneur First and Form Ventures to expand its platform into clinical settings.
"Our technology is revolutionary. By combining cutting edge neuroscience and ethical, explainable AI, we have built a tool that can help people get an accurate diagnosis and effective treatment plan in place faster than ever before. It’s all about arming clinicians with the very best tools so that they can do the very best by their patients. We’re so grateful for the support our investors have shown us so far; and we look forward to this next stage of our journey as we look to optimise and expand our technology and get it in the hands of the people who need it most."
